Commentary

Podcast

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

In this PER On Air Ophthalmology Times podcast, an expert panel discusses the latest advances in X-linked retinitis pigmentosa and how to optimize diagnosis as well as developments in gene therapy.

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

In this PER On Air Ophthalmology Times podcast, an expert panel discusses the latest advances in X-linked retinitis pigmentosa and how to optimize diagnosis as well as developments in gene therapy.

Mark Pennesi, MD, PhD, FARVO

Director, Ophthalmic Genetics, Retina Foundation, Professor of Ophthalmology, Professor of Molecular and Medical Genetics, Paul H. Casey Ophthalmic Genetics Division, Casey Eye Institute, Oregon Health & Science University, Dallas, TX

Laxmi V. Devisetty, MD

Ophthalmologist, Retina Specialist, Vitreoretinal Surgeon, NJRetina, Union, NJ

M. Dominik Fischer, MD, DPhil, FEBO, MRCOphth

Consultant Ophthalmologist Surgeon, Oxford Eye Hospital

Professor of Ophthalmology, University of Oxford, Oxford, England

Ramiro Maldonado, MD

Co-Director Pediatric Retina, Director IRD Fellowship, Ophthalmic Genetics Center, Duke University Eye Center, Durham, NC

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
© 2025 MJH Life Sciences

All rights reserved.